Riyadh Medical Biotechnology Summit Produces More Than Forty Agreements and Initiatives Worth Over Five Billion Riyals
The Riyadh Global Medical Biotechnology Summit concluded with more than forty agreements, initiatives and investment announcements carrying an estimated value above five billion Saudi riyals, with the outcomes focused on biotechnology localization, advanced pharmaceutical industries and Saudi Arabia’s national life-sciences ambitions. ([SaudiCon][8])